ÂÜÀòÂÒÂ×

Tone Aase Fykerud has a diverse work experience spanning several years. Their most recent role is as a Scientist at Nykode Therapeutics, starting in August 2021. Prior to that, they worked at PHARMAQ, where they held the position of Scientist/Process Technologist from April 2016 to July 2021. In this role, they were responsible for method development, problem-solving, and providing professional support for vaccine production. They also worked on method validations, product transfers, and process development projects. Their work at PHARMAQ involved close collaboration with quality control in vaccine production.

Before joining PHARMAQ, Tone Aase Fykerud worked at The Norwegian Radium Hospital. They started as a Research Associate in August 2010 and later became a PhD student in March 2013. Their PhD research focused on the role of the NEDD4 family of E3 ubiquitin ligases in the regulation of intercellular communication via gap junctions. Their lab skills included cell culture and immuno-based methods.

Overall, Tone Aase Fykerud has a strong background in scientific research and development, with expertise in method development, problem-solving, and vaccine production.

Tone Aase Fykerud has a diverse education history. Tone Aase attended the Norwegian University of Science and Technology (NTNU) in 2004 to 2005, where they studied Chemistry. Tone Aase then transferred to the University of Oslo (UiO) and completed their Bachelor of Science degree in Molecular Biology from 2005 to 2008. In 2008, they pursued their Master's degree in Molecular Biology at the University of Oslo (UiO) until 2010. Additionally, in the same year, they also studied Molecular Biology at Griffith University for a brief period. Lastly, from 2013 to 2017, Tone Aase Fykerud pursued their Doctor of Philosophy (Ph.D.) degree at the University of Oslo (UiO) in the field of Cell/Cellular and Molecular Biology.